nodes	percent_of_prediction	percent_of_DWPC	metapath
Memantine—CYP2A6—esophageal cancer	0.641	1	CbGaD
Memantine—SLC22A2—Cisplatin—esophageal cancer	0.0618	0.658	CbGbCtD
Memantine—CYP2B6—Cisplatin—esophageal cancer	0.0321	0.342	CbGbCtD
Memantine—Eye disorder—Cisplatin—esophageal cancer	0.000315	0.00183	CcSEcCtD
Memantine—Tinnitus—Cisplatin—esophageal cancer	0.000314	0.00183	CcSEcCtD
Memantine—Flushing—Cisplatin—esophageal cancer	0.000313	0.00182	CcSEcCtD
Memantine—Cardiac disorder—Cisplatin—esophageal cancer	0.000313	0.00182	CcSEcCtD
Memantine—Asthma—Capecitabine—esophageal cancer	0.00031	0.0018	CcSEcCtD
Memantine—Influenza—Capecitabine—esophageal cancer	0.00031	0.0018	CcSEcCtD
Memantine—Dysphagia—Capecitabine—esophageal cancer	0.00031	0.0018	CcSEcCtD
Memantine—Thrombophlebitis—Methotrexate—esophageal cancer	0.000309	0.00179	CcSEcCtD
Memantine—Diabetes mellitus—Methotrexate—esophageal cancer	0.000307	0.00179	CcSEcCtD
Memantine—Bronchospasm—Capecitabine—esophageal cancer	0.000305	0.00177	CcSEcCtD
Memantine—Polyuria—Methotrexate—esophageal cancer	0.000304	0.00177	CcSEcCtD
Memantine—Immune system disorder—Cisplatin—esophageal cancer	0.000304	0.00177	CcSEcCtD
Memantine—Mediastinal disorder—Cisplatin—esophageal cancer	0.000304	0.00176	CcSEcCtD
Memantine—Angina pectoris—Capecitabine—esophageal cancer	0.000302	0.00176	CcSEcCtD
Memantine—Sweating increased—Capecitabine—esophageal cancer	0.000302	0.00176	CcSEcCtD
Memantine—Arrhythmia—Cisplatin—esophageal cancer	0.000301	0.00175	CcSEcCtD
Memantine—Bronchitis—Capecitabine—esophageal cancer	0.000298	0.00173	CcSEcCtD
Memantine—Alopecia—Cisplatin—esophageal cancer	0.000298	0.00173	CcSEcCtD
Memantine—Hepatic failure—Methotrexate—esophageal cancer	0.000297	0.00173	CcSEcCtD
Memantine—Pancytopenia—Capecitabine—esophageal cancer	0.000295	0.00171	CcSEcCtD
Memantine—Malnutrition—Cisplatin—esophageal cancer	0.000293	0.0017	CcSEcCtD
Memantine—Neutropenia—Capecitabine—esophageal cancer	0.00029	0.00169	CcSEcCtD
Memantine—Dysuria—Capecitabine—esophageal cancer	0.00029	0.00169	CcSEcCtD
Memantine—Renal failure acute—Methotrexate—esophageal cancer	0.000289	0.00168	CcSEcCtD
Memantine—Flatulence—Cisplatin—esophageal cancer	0.000289	0.00168	CcSEcCtD
Memantine—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000288	0.00168	CcSEcCtD
Memantine—Weight increased—Capecitabine—esophageal cancer	0.000282	0.00164	CcSEcCtD
Memantine—Weight decreased—Capecitabine—esophageal cancer	0.000281	0.00163	CcSEcCtD
Memantine—Hyperglycaemia—Capecitabine—esophageal cancer	0.00028	0.00163	CcSEcCtD
Memantine—Pneumonia—Capecitabine—esophageal cancer	0.000278	0.00162	CcSEcCtD
Memantine—Infestation NOS—Capecitabine—esophageal cancer	0.000277	0.00161	CcSEcCtD
Memantine—Infestation—Capecitabine—esophageal cancer	0.000277	0.00161	CcSEcCtD
Memantine—Vision blurred—Cisplatin—esophageal cancer	0.000276	0.00161	CcSEcCtD
Memantine—Depression—Capecitabine—esophageal cancer	0.000276	0.0016	CcSEcCtD
Memantine—Tremor—Cisplatin—esophageal cancer	0.000275	0.0016	CcSEcCtD
Memantine—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000274	0.00159	CcSEcCtD
Memantine—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000273	0.00158	CcSEcCtD
Memantine—Lethargy—Methotrexate—esophageal cancer	0.000273	0.00158	CcSEcCtD
Memantine—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000273	0.00158	CcSEcCtD
Memantine—Ill-defined disorder—Cisplatin—esophageal cancer	0.000272	0.00158	CcSEcCtD
Memantine—Renal failure—Capecitabine—esophageal cancer	0.000272	0.00158	CcSEcCtD
Memantine—Myocardial infarction—Capecitabine—esophageal cancer	0.000271	0.00158	CcSEcCtD
Memantine—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000271	0.00158	CcSEcCtD
Memantine—Anaemia—Cisplatin—esophageal cancer	0.000271	0.00158	CcSEcCtD
Memantine—Conjunctivitis—Capecitabine—esophageal cancer	0.000269	0.00156	CcSEcCtD
Memantine—Urinary tract infection—Capecitabine—esophageal cancer	0.000269	0.00156	CcSEcCtD
Memantine—Osteoarthritis—Methotrexate—esophageal cancer	0.000267	0.00155	CcSEcCtD
Memantine—Malaise—Cisplatin—esophageal cancer	0.000264	0.00154	CcSEcCtD
Memantine—Haematuria—Capecitabine—esophageal cancer	0.000264	0.00153	CcSEcCtD
Memantine—Leukopenia—Cisplatin—esophageal cancer	0.000262	0.00153	CcSEcCtD
Memantine—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000262	0.00152	CcSEcCtD
Memantine—Epistaxis—Capecitabine—esophageal cancer	0.000261	0.00152	CcSEcCtD
Memantine—Agranulocytosis—Capecitabine—esophageal cancer	0.000258	0.0015	CcSEcCtD
Memantine—Irritability—Methotrexate—esophageal cancer	0.000255	0.00148	CcSEcCtD
Memantine—Convulsion—Cisplatin—esophageal cancer	0.000254	0.00148	CcSEcCtD
Memantine—Mood swings—Methotrexate—esophageal cancer	0.000253	0.00147	CcSEcCtD
Memantine—Bradycardia—Capecitabine—esophageal cancer	0.000253	0.00147	CcSEcCtD
Memantine—Ataxia—Methotrexate—esophageal cancer	0.000251	0.00146	CcSEcCtD
Memantine—Myalgia—Cisplatin—esophageal cancer	0.00025	0.00145	CcSEcCtD
Memantine—Haemoglobin—Capecitabine—esophageal cancer	0.00025	0.00145	CcSEcCtD
Memantine—Rhinitis—Capecitabine—esophageal cancer	0.000249	0.00145	CcSEcCtD
Memantine—Anxiety—Cisplatin—esophageal cancer	0.000249	0.00145	CcSEcCtD
Memantine—Haemorrhage—Capecitabine—esophageal cancer	0.000248	0.00144	CcSEcCtD
Memantine—Hepatitis—Capecitabine—esophageal cancer	0.000248	0.00144	CcSEcCtD
Memantine—Hypoaesthesia—Capecitabine—esophageal cancer	0.000247	0.00144	CcSEcCtD
Memantine—Liver function test abnormal—Methotrexate—esophageal cancer	0.000247	0.00143	CcSEcCtD
Memantine—Discomfort—Cisplatin—esophageal cancer	0.000247	0.00143	CcSEcCtD
Memantine—Pharyngitis—Capecitabine—esophageal cancer	0.000246	0.00143	CcSEcCtD
Memantine—Urinary tract disorder—Capecitabine—esophageal cancer	0.000245	0.00143	CcSEcCtD
Memantine—Oedema peripheral—Capecitabine—esophageal cancer	0.000245	0.00142	CcSEcCtD
Memantine—Connective tissue disorder—Capecitabine—esophageal cancer	0.000244	0.00142	CcSEcCtD
Memantine—Urethral disorder—Capecitabine—esophageal cancer	0.000243	0.00141	CcSEcCtD
Memantine—Oedema—Cisplatin—esophageal cancer	0.000239	0.00139	CcSEcCtD
Memantine—Visual impairment—Capecitabine—esophageal cancer	0.000239	0.00139	CcSEcCtD
Memantine—Infection—Cisplatin—esophageal cancer	0.000238	0.00138	CcSEcCtD
Memantine—Erythema multiforme—Capecitabine—esophageal cancer	0.000235	0.00136	CcSEcCtD
Memantine—Nervous system disorder—Cisplatin—esophageal cancer	0.000235	0.00136	CcSEcCtD
Memantine—Thrombocytopenia—Cisplatin—esophageal cancer	0.000234	0.00136	CcSEcCtD
Memantine—Tachycardia—Cisplatin—esophageal cancer	0.000234	0.00136	CcSEcCtD
Memantine—Skin disorder—Cisplatin—esophageal cancer	0.000232	0.00135	CcSEcCtD
Memantine—Eye disorder—Capecitabine—esophageal cancer	0.000232	0.00135	CcSEcCtD
Memantine—Tinnitus—Capecitabine—esophageal cancer	0.000231	0.00135	CcSEcCtD
Memantine—Hyperhidrosis—Cisplatin—esophageal cancer	0.000231	0.00134	CcSEcCtD
Memantine—Asthma—Methotrexate—esophageal cancer	0.000231	0.00134	CcSEcCtD
Memantine—Flushing—Capecitabine—esophageal cancer	0.00023	0.00134	CcSEcCtD
Memantine—Cardiac disorder—Capecitabine—esophageal cancer	0.00023	0.00134	CcSEcCtD
Memantine—Anorexia—Cisplatin—esophageal cancer	0.000228	0.00133	CcSEcCtD
Memantine—Pancreatitis—Methotrexate—esophageal cancer	0.000226	0.00132	CcSEcCtD
Memantine—Angiopathy—Capecitabine—esophageal cancer	0.000225	0.00131	CcSEcCtD
Memantine—Immune system disorder—Capecitabine—esophageal cancer	0.000224	0.0013	CcSEcCtD
Memantine—Mediastinal disorder—Capecitabine—esophageal cancer	0.000224	0.0013	CcSEcCtD
Memantine—Hypotension—Cisplatin—esophageal cancer	0.000224	0.0013	CcSEcCtD
Memantine—Chills—Capecitabine—esophageal cancer	0.000223	0.00129	CcSEcCtD
Memantine—Arrhythmia—Capecitabine—esophageal cancer	0.000222	0.00129	CcSEcCtD
Memantine—Alopecia—Capecitabine—esophageal cancer	0.000219	0.00128	CcSEcCtD
Memantine—Pancytopenia—Methotrexate—esophageal cancer	0.000219	0.00127	CcSEcCtD
Memantine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000218	0.00127	CcSEcCtD
Memantine—Mental disorder—Capecitabine—esophageal cancer	0.000217	0.00126	CcSEcCtD
Memantine—Malnutrition—Capecitabine—esophageal cancer	0.000216	0.00126	CcSEcCtD
Memantine—Dysuria—Methotrexate—esophageal cancer	0.000216	0.00126	CcSEcCtD
Memantine—Neutropenia—Methotrexate—esophageal cancer	0.000216	0.00126	CcSEcCtD
Memantine—Paraesthesia—Cisplatin—esophageal cancer	0.000215	0.00125	CcSEcCtD
Memantine—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000215	0.00125	CcSEcCtD
Memantine—Dyspnoea—Cisplatin—esophageal cancer	0.000213	0.00124	CcSEcCtD
Memantine—Flatulence—Capecitabine—esophageal cancer	0.000213	0.00124	CcSEcCtD
Memantine—Erectile dysfunction—Methotrexate—esophageal cancer	0.000213	0.00124	CcSEcCtD
Memantine—Dysgeusia—Capecitabine—esophageal cancer	0.000212	0.00123	CcSEcCtD
Memantine—Back pain—Capecitabine—esophageal cancer	0.000209	0.00122	CcSEcCtD
Memantine—Decreased appetite—Cisplatin—esophageal cancer	0.000208	0.00121	CcSEcCtD
Memantine—Pneumonia—Methotrexate—esophageal cancer	0.000207	0.0012	CcSEcCtD
Memantine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000207	0.0012	CcSEcCtD
Memantine—Infestation NOS—Methotrexate—esophageal cancer	0.000206	0.0012	CcSEcCtD
Memantine—Infestation—Methotrexate—esophageal cancer	0.000206	0.0012	CcSEcCtD
Memantine—Depression—Methotrexate—esophageal cancer	0.000205	0.00119	CcSEcCtD
Memantine—Pain—Cisplatin—esophageal cancer	0.000205	0.00119	CcSEcCtD
Memantine—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000204	0.00119	CcSEcCtD
Memantine—Vision blurred—Capecitabine—esophageal cancer	0.000204	0.00118	CcSEcCtD
Memantine—Tremor—Capecitabine—esophageal cancer	0.000202	0.00118	CcSEcCtD
Memantine—Renal failure—Methotrexate—esophageal cancer	0.000202	0.00118	CcSEcCtD
Memantine—Ill-defined disorder—Capecitabine—esophageal cancer	0.000201	0.00117	CcSEcCtD
Memantine—Conjunctivitis—Methotrexate—esophageal cancer	0.0002	0.00116	CcSEcCtD
Memantine—Anaemia—Capecitabine—esophageal cancer	0.0002	0.00116	CcSEcCtD
Memantine—Feeling abnormal—Cisplatin—esophageal cancer	0.000197	0.00115	CcSEcCtD
Memantine—Haematuria—Methotrexate—esophageal cancer	0.000196	0.00114	CcSEcCtD
Memantine—Malaise—Capecitabine—esophageal cancer	0.000195	0.00113	CcSEcCtD
Memantine—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000195	0.00113	CcSEcCtD
Memantine—Epistaxis—Methotrexate—esophageal cancer	0.000194	0.00113	CcSEcCtD
Memantine—Vertigo—Capecitabine—esophageal cancer	0.000194	0.00113	CcSEcCtD
Memantine—Syncope—Capecitabine—esophageal cancer	0.000194	0.00113	CcSEcCtD
Memantine—Leukopenia—Capecitabine—esophageal cancer	0.000193	0.00112	CcSEcCtD
Memantine—Agranulocytosis—Methotrexate—esophageal cancer	0.000192	0.00112	CcSEcCtD
Memantine—Palpitations—Capecitabine—esophageal cancer	0.000191	0.00111	CcSEcCtD
Memantine—Loss of consciousness—Capecitabine—esophageal cancer	0.00019	0.0011	CcSEcCtD
Memantine—Body temperature increased—Cisplatin—esophageal cancer	0.000189	0.0011	CcSEcCtD
Memantine—Cough—Capecitabine—esophageal cancer	0.000189	0.0011	CcSEcCtD
Memantine—Hypertension—Capecitabine—esophageal cancer	0.000187	0.00108	CcSEcCtD
Memantine—Haemoglobin—Methotrexate—esophageal cancer	0.000186	0.00108	CcSEcCtD
Memantine—Hepatitis—Methotrexate—esophageal cancer	0.000185	0.00107	CcSEcCtD
Memantine—Haemorrhage—Methotrexate—esophageal cancer	0.000185	0.00107	CcSEcCtD
Memantine—Myalgia—Capecitabine—esophageal cancer	0.000184	0.00107	CcSEcCtD
Memantine—Chest pain—Capecitabine—esophageal cancer	0.000184	0.00107	CcSEcCtD
Memantine—Arthralgia—Capecitabine—esophageal cancer	0.000184	0.00107	CcSEcCtD
Memantine—Pharyngitis—Methotrexate—esophageal cancer	0.000183	0.00107	CcSEcCtD
Memantine—Anxiety—Capecitabine—esophageal cancer	0.000183	0.00107	CcSEcCtD
Memantine—Urinary tract disorder—Methotrexate—esophageal cancer	0.000182	0.00106	CcSEcCtD
Memantine—Discomfort—Capecitabine—esophageal cancer	0.000182	0.00106	CcSEcCtD
Memantine—Urethral disorder—Methotrexate—esophageal cancer	0.000181	0.00105	CcSEcCtD
Memantine—Dry mouth—Capecitabine—esophageal cancer	0.00018	0.00105	CcSEcCtD
Memantine—Visual impairment—Methotrexate—esophageal cancer	0.000178	0.00104	CcSEcCtD
Memantine—Confusional state—Capecitabine—esophageal cancer	0.000178	0.00103	CcSEcCtD
Memantine—Oedema—Capecitabine—esophageal cancer	0.000176	0.00103	CcSEcCtD
Memantine—Hypersensitivity—Cisplatin—esophageal cancer	0.000176	0.00102	CcSEcCtD
Memantine—Infection—Capecitabine—esophageal cancer	0.000175	0.00102	CcSEcCtD
Memantine—Erythema multiforme—Methotrexate—esophageal cancer	0.000175	0.00102	CcSEcCtD
Memantine—Shock—Capecitabine—esophageal cancer	0.000174	0.00101	CcSEcCtD
Memantine—Nervous system disorder—Capecitabine—esophageal cancer	0.000173	0.00101	CcSEcCtD
Memantine—Eye disorder—Methotrexate—esophageal cancer	0.000173	0.001	CcSEcCtD
Memantine—Thrombocytopenia—Capecitabine—esophageal cancer	0.000173	0.001	CcSEcCtD
Memantine—Tinnitus—Methotrexate—esophageal cancer	0.000172	0.001	CcSEcCtD
Memantine—Tachycardia—Capecitabine—esophageal cancer	0.000172	0.001	CcSEcCtD
Memantine—Asthenia—Cisplatin—esophageal cancer	0.000172	0.000998	CcSEcCtD
Memantine—Cardiac disorder—Methotrexate—esophageal cancer	0.000172	0.000997	CcSEcCtD
Memantine—Skin disorder—Capecitabine—esophageal cancer	0.000171	0.000996	CcSEcCtD
Memantine—Hyperhidrosis—Capecitabine—esophageal cancer	0.00017	0.000991	CcSEcCtD
Memantine—Anorexia—Capecitabine—esophageal cancer	0.000168	0.000977	CcSEcCtD
Memantine—Angiopathy—Methotrexate—esophageal cancer	0.000168	0.000975	CcSEcCtD
Memantine—Immune system disorder—Methotrexate—esophageal cancer	0.000167	0.00097	CcSEcCtD
Memantine—Mediastinal disorder—Methotrexate—esophageal cancer	0.000167	0.000968	CcSEcCtD
Memantine—Chills—Methotrexate—esophageal cancer	0.000166	0.000964	CcSEcCtD
Memantine—Hypotension—Capecitabine—esophageal cancer	0.000165	0.000958	CcSEcCtD
Memantine—Diarrhoea—Cisplatin—esophageal cancer	0.000164	0.000952	CcSEcCtD
Memantine—Alopecia—Methotrexate—esophageal cancer	0.000163	0.000949	CcSEcCtD
Memantine—Mental disorder—Methotrexate—esophageal cancer	0.000162	0.000941	CcSEcCtD
Memantine—Malnutrition—Methotrexate—esophageal cancer	0.000161	0.000935	CcSEcCtD
Memantine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000161	0.000934	CcSEcCtD
Memantine—Insomnia—Capecitabine—esophageal cancer	0.00016	0.000927	CcSEcCtD
Memantine—Paraesthesia—Capecitabine—esophageal cancer	0.000158	0.000921	CcSEcCtD
Memantine—Dysgeusia—Methotrexate—esophageal cancer	0.000158	0.000916	CcSEcCtD
Memantine—Dyspnoea—Capecitabine—esophageal cancer	0.000157	0.000914	CcSEcCtD
Memantine—Back pain—Methotrexate—esophageal cancer	0.000156	0.000905	CcSEcCtD
Memantine—Dyspepsia—Capecitabine—esophageal cancer	0.000155	0.000902	CcSEcCtD
Memantine—Decreased appetite—Capecitabine—esophageal cancer	0.000153	0.000891	CcSEcCtD
Memantine—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000152	0.000885	CcSEcCtD
Memantine—Vomiting—Cisplatin—esophageal cancer	0.000152	0.000884	CcSEcCtD
Memantine—Fatigue—Capecitabine—esophageal cancer	0.000152	0.000884	CcSEcCtD
Memantine—Vision blurred—Methotrexate—esophageal cancer	0.000152	0.000881	CcSEcCtD
Memantine—Rash—Cisplatin—esophageal cancer	0.000151	0.000877	CcSEcCtD
Memantine—Pain—Capecitabine—esophageal cancer	0.000151	0.000877	CcSEcCtD
Memantine—Constipation—Capecitabine—esophageal cancer	0.000151	0.000877	CcSEcCtD
Memantine—Dermatitis—Cisplatin—esophageal cancer	0.000151	0.000876	CcSEcCtD
Memantine—Ill-defined disorder—Methotrexate—esophageal cancer	0.000149	0.000868	CcSEcCtD
Memantine—Anaemia—Methotrexate—esophageal cancer	0.000149	0.000864	CcSEcCtD
Memantine—Feeling abnormal—Capecitabine—esophageal cancer	0.000145	0.000845	CcSEcCtD
Memantine—Malaise—Methotrexate—esophageal cancer	0.000145	0.000843	CcSEcCtD
Memantine—Vertigo—Methotrexate—esophageal cancer	0.000145	0.00084	CcSEcCtD
Memantine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000144	0.000838	CcSEcCtD
Memantine—Leukopenia—Methotrexate—esophageal cancer	0.000144	0.000837	CcSEcCtD
Memantine—Nausea—Cisplatin—esophageal cancer	0.000142	0.000826	CcSEcCtD
Memantine—Cough—Methotrexate—esophageal cancer	0.00014	0.000816	CcSEcCtD
Memantine—Urticaria—Capecitabine—esophageal cancer	0.00014	0.000814	CcSEcCtD
Memantine—Abdominal pain—Capecitabine—esophageal cancer	0.000139	0.00081	CcSEcCtD
Memantine—Body temperature increased—Capecitabine—esophageal cancer	0.000139	0.00081	CcSEcCtD
Memantine—Convulsion—Methotrexate—esophageal cancer	0.000139	0.00081	CcSEcCtD
Memantine—Myalgia—Methotrexate—esophageal cancer	0.000137	0.000796	CcSEcCtD
Memantine—Chest pain—Methotrexate—esophageal cancer	0.000137	0.000796	CcSEcCtD
Memantine—Arthralgia—Methotrexate—esophageal cancer	0.000137	0.000796	CcSEcCtD
Memantine—Discomfort—Methotrexate—esophageal cancer	0.000135	0.000787	CcSEcCtD
Memantine—Confusional state—Methotrexate—esophageal cancer	0.000132	0.00077	CcSEcCtD
Memantine—Infection—Methotrexate—esophageal cancer	0.00013	0.000758	CcSEcCtD
Memantine—Hypersensitivity—Capecitabine—esophageal cancer	0.00013	0.000755	CcSEcCtD
Memantine—Nervous system disorder—Methotrexate—esophageal cancer	0.000129	0.000748	CcSEcCtD
Memantine—Thrombocytopenia—Methotrexate—esophageal cancer	0.000129	0.000747	CcSEcCtD
Memantine—Skin disorder—Methotrexate—esophageal cancer	0.000128	0.000741	CcSEcCtD
Memantine—Hyperhidrosis—Methotrexate—esophageal cancer	0.000127	0.000738	CcSEcCtD
Memantine—Asthenia—Capecitabine—esophageal cancer	0.000127	0.000736	CcSEcCtD
Memantine—Anorexia—Methotrexate—esophageal cancer	0.000125	0.000728	CcSEcCtD
Memantine—Pruritus—Capecitabine—esophageal cancer	0.000125	0.000725	CcSEcCtD
Memantine—Hypotension—Methotrexate—esophageal cancer	0.000123	0.000713	CcSEcCtD
Memantine—Diarrhoea—Capecitabine—esophageal cancer	0.000121	0.000701	CcSEcCtD
Memantine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00012	0.000695	CcSEcCtD
Memantine—Insomnia—Methotrexate—esophageal cancer	0.000119	0.00069	CcSEcCtD
Memantine—Paraesthesia—Methotrexate—esophageal cancer	0.000118	0.000685	CcSEcCtD
Memantine—Dyspnoea—Methotrexate—esophageal cancer	0.000117	0.00068	CcSEcCtD
Memantine—Somnolence—Methotrexate—esophageal cancer	0.000117	0.000679	CcSEcCtD
Memantine—Dizziness—Capecitabine—esophageal cancer	0.000117	0.000678	CcSEcCtD
Memantine—Dyspepsia—Methotrexate—esophageal cancer	0.000116	0.000672	CcSEcCtD
Memantine—Decreased appetite—Methotrexate—esophageal cancer	0.000114	0.000663	CcSEcCtD
Memantine—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000113	0.000659	CcSEcCtD
Memantine—Fatigue—Methotrexate—esophageal cancer	0.000113	0.000658	CcSEcCtD
Memantine—Pain—Methotrexate—esophageal cancer	0.000112	0.000653	CcSEcCtD
Memantine—Vomiting—Capecitabine—esophageal cancer	0.000112	0.000652	CcSEcCtD
Memantine—Rash—Capecitabine—esophageal cancer	0.000111	0.000646	CcSEcCtD
Memantine—Dermatitis—Capecitabine—esophageal cancer	0.000111	0.000646	CcSEcCtD
Memantine—Headache—Capecitabine—esophageal cancer	0.00011	0.000642	CcSEcCtD
Memantine—Feeling abnormal—Methotrexate—esophageal cancer	0.000108	0.000629	CcSEcCtD
Memantine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000107	0.000624	CcSEcCtD
Memantine—Nausea—Capecitabine—esophageal cancer	0.000105	0.000609	CcSEcCtD
Memantine—Urticaria—Methotrexate—esophageal cancer	0.000104	0.000606	CcSEcCtD
Memantine—Body temperature increased—Methotrexate—esophageal cancer	0.000104	0.000603	CcSEcCtD
Memantine—Abdominal pain—Methotrexate—esophageal cancer	0.000104	0.000603	CcSEcCtD
Memantine—Hypersensitivity—Methotrexate—esophageal cancer	9.67e-05	0.000562	CcSEcCtD
Memantine—Asthenia—Methotrexate—esophageal cancer	9.42e-05	0.000548	CcSEcCtD
Memantine—Pruritus—Methotrexate—esophageal cancer	9.29e-05	0.00054	CcSEcCtD
Memantine—Diarrhoea—Methotrexate—esophageal cancer	8.98e-05	0.000522	CcSEcCtD
Memantine—CYP2C19—Biological oxidations—GSTT1—esophageal cancer	8.94e-05	0.000961	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—TP53—esophageal cancer	8.88e-05	0.000955	CbGpPWpGaD
Memantine—CYP2B6—Biological oxidations—CYP19A1—esophageal cancer	8.87e-05	0.000953	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—ABCB1—esophageal cancer	8.85e-05	0.000951	CbGpPWpGaD
Memantine—CYP2C19—Biological oxidations—CYP2A6—esophageal cancer	8.84e-05	0.00095	CbGpPWpGaD
Memantine—CYP2B6—Metapathway biotransformation—CYP19A1—esophageal cancer	8.75e-05	0.00094	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—ABL1—esophageal cancer	8.73e-05	0.000938	CbGpPWpGaD
Memantine—Dizziness—Methotrexate—esophageal cancer	8.68e-05	0.000505	CcSEcCtD
Memantine—GRIN1—Developmental Biology—SMAD4—esophageal cancer	8.67e-05	0.000932	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL2—esophageal cancer	8.64e-05	0.000928	CbGpPWpGaD
Memantine—CYP2C19—Arachidonic acid metabolism—PTGS2—esophageal cancer	8.63e-05	0.000928	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—SMAD4—esophageal cancer	8.45e-05	0.000909	CbGpPWpGaD
Memantine—CYP2C19—Biological oxidations—PTGS1—esophageal cancer	8.38e-05	0.000901	CbGpPWpGaD
Memantine—Vomiting—Methotrexate—esophageal cancer	8.35e-05	0.000485	CcSEcCtD
Memantine—Rash—Methotrexate—esophageal cancer	8.28e-05	0.000481	CcSEcCtD
Memantine—Dermatitis—Methotrexate—esophageal cancer	8.27e-05	0.000481	CcSEcCtD
Memantine—Headache—Methotrexate—esophageal cancer	8.22e-05	0.000478	CcSEcCtD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—ANXA1—esophageal cancer	8.03e-05	0.000863	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—SST—esophageal cancer	7.81e-05	0.000839	CbGpPWpGaD
Memantine—Nausea—Methotrexate—esophageal cancer	7.8e-05	0.000453	CcSEcCtD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—GHRL—esophageal cancer	7.61e-05	0.000818	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—ADCYAP1—esophageal cancer	7.52e-05	0.000809	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—GNG7—esophageal cancer	7.46e-05	0.000802	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—ABCC2—esophageal cancer	7.22e-05	0.000775	CbGpPWpGaD
Memantine—CYP2C19—Biological oxidations—CYP1B1—esophageal cancer	7.13e-05	0.000766	CbGpPWpGaD
Memantine—CYP2C19—Metapathway biotransformation—CYP1B1—esophageal cancer	7.03e-05	0.000755	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	6.87e-05	0.000739	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—ADCYAP1—esophageal cancer	6.83e-05	0.000734	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—ERBB2—esophageal cancer	6.8e-05	0.000731	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—KDR—esophageal cancer	6.79e-05	0.000729	CbGpPWpGaD
Memantine—CYP2C19—Biological oxidations—CYP19A1—esophageal cancer	6.7e-05	0.00072	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—MET—esophageal cancer	6.64e-05	0.000714	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—ERBB2—esophageal cancer	6.63e-05	0.000713	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—KDR—esophageal cancer	6.62e-05	0.000711	CbGpPWpGaD
Memantine—CYP2C19—Metapathway biotransformation—CYP19A1—esophageal cancer	6.61e-05	0.00071	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—CXCL2—esophageal cancer	6.58e-05	0.000707	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—GNG7—esophageal cancer	6.55e-05	0.000704	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—MET—esophageal cancer	6.47e-05	0.000696	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—BLVRB—esophageal cancer	6.43e-05	0.000691	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—SLC52A3—esophageal cancer	6.43e-05	0.000691	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—NOTCH1—esophageal cancer	6.39e-05	0.000687	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GDI2—esophageal cancer	6.26e-05	0.000673	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—NOTCH1—esophageal cancer	6.23e-05	0.00067	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—ANXA1—esophageal cancer	6.11e-05	0.000657	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—NOS2—esophageal cancer	6.08e-05	0.000653	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—SST—esophageal cancer	5.95e-05	0.000639	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—CREBBP—esophageal cancer	5.92e-05	0.000636	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—BLVRB—esophageal cancer	5.91e-05	0.000635	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—SLC52A3—esophageal cancer	5.91e-05	0.000635	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—CREBBP—esophageal cancer	5.8e-05	0.000623	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—GHRL—esophageal cancer	5.8e-05	0.000623	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—CREBBP—esophageal cancer	5.65e-05	0.000607	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CA1—esophageal cancer	5.47e-05	0.000588	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—SLC10A2—esophageal cancer	5.47e-05	0.000588	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CA1—esophageal cancer	5.02e-05	0.00054	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—SLC10A2—esophageal cancer	5.02e-05	0.00054	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CA2—esophageal cancer	5e-05	0.000538	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—ERBB2—esophageal cancer	4.85e-05	0.000522	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—AKAP13—esophageal cancer	4.85e-05	0.000521	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—BLVRB—esophageal cancer	4.76e-05	0.000512	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—SLC52A3—esophageal cancer	4.76e-05	0.000512	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—ERBB2—esophageal cancer	4.73e-05	0.000509	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—EGFR—esophageal cancer	4.71e-05	0.000507	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ADH7—esophageal cancer	4.65e-05	0.0005	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PLCE1—esophageal cancer	4.65e-05	0.0005	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	4.64e-05	0.000499	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—EGFR—esophageal cancer	4.6e-05	0.000494	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CA2—esophageal cancer	4.59e-05	0.000494	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—KMT2D—esophageal cancer	4.53e-05	0.000487	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PDE4D—esophageal cancer	4.43e-05	0.000477	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—AKAP13—esophageal cancer	4.4e-05	0.000473	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ADH7—esophageal cancer	4.27e-05	0.000459	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PLCE1—esophageal cancer	4.27e-05	0.000459	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—GNG7—esophageal cancer	4.22e-05	0.000453	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ADH1B—esophageal cancer	4.08e-05	0.000438	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	4.05e-05	0.000435	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CA1—esophageal cancer	4.05e-05	0.000435	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—SLC10A2—esophageal cancer	4.05e-05	0.000435	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ADCYAP1—esophageal cancer	4.04e-05	0.000434	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PDE4D—esophageal cancer	4.03e-05	0.000433	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.99e-05	0.000429	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—EP300—esophageal cancer	3.95e-05	0.000424	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—TYMP—esophageal cancer	3.9e-05	0.000419	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—EP300—esophageal cancer	3.85e-05	0.000414	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—GNG7—esophageal cancer	3.83e-05	0.000412	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	3.83e-05	0.000411	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CYP26A1—esophageal cancer	3.79e-05	0.000407	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ADH1B—esophageal cancer	3.74e-05	0.000402	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—EP300—esophageal cancer	3.72e-05	0.0004	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CXCL2—esophageal cancer	3.72e-05	0.000399	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CA2—esophageal cancer	3.71e-05	0.000398	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ALOX15—esophageal cancer	3.69e-05	0.000397	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—WWOX—esophageal cancer	3.69e-05	0.000397	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—BLVRB—esophageal cancer	3.6e-05	0.000387	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—SLC52A3—esophageal cancer	3.6e-05	0.000387	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—TYMP—esophageal cancer	3.58e-05	0.000385	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GSTO1—esophageal cancer	3.52e-05	0.000379	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—TPI1—esophageal cancer	3.52e-05	0.000379	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—FKBP1A—esophageal cancer	3.51e-05	0.000377	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CYP26A1—esophageal cancer	3.48e-05	0.000374	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—ANXA1—esophageal cancer	3.45e-05	0.000371	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ADH7—esophageal cancer	3.44e-05	0.00037	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PLCE1—esophageal cancer	3.44e-05	0.00037	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—WIF1—esophageal cancer	3.43e-05	0.000369	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ALOX15—esophageal cancer	3.39e-05	0.000365	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ALDOB—esophageal cancer	3.38e-05	0.000363	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CXCL2—esophageal cancer	3.37e-05	0.000363	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—EGFR—esophageal cancer	3.36e-05	0.000362	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—SST—esophageal cancer	3.36e-05	0.000361	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—EGFR—esophageal cancer	3.28e-05	0.000352	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—GHRL—esophageal cancer	3.28e-05	0.000352	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GAPDH—esophageal cancer	3.25e-05	0.00035	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—TPI1—esophageal cancer	3.24e-05	0.000348	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GSTO1—esophageal cancer	3.24e-05	0.000348	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CRABP1—esophageal cancer	3.22e-05	0.000346	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	3.22e-05	0.000346	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CSNK1A1—esophageal cancer	3.17e-05	0.00034	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—ANXA1—esophageal cancer	3.14e-05	0.000337	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ALDOB—esophageal cancer	3.1e-05	0.000333	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GNG7—esophageal cancer	3.07e-05	0.00033	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—SLC10A2—esophageal cancer	3.06e-05	0.000329	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CA1—esophageal cancer	3.06e-05	0.000329	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—SST—esophageal cancer	3.05e-05	0.000328	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ADH1B—esophageal cancer	3.02e-05	0.000325	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GAPDH—esophageal cancer	2.99e-05	0.000321	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—GHRL—esophageal cancer	2.97e-05	0.00032	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PFN1—esophageal cancer	2.96e-05	0.000318	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CRABP1—esophageal cancer	2.96e-05	0.000318	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—TYMP—esophageal cancer	2.89e-05	0.00031	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ALDH2—esophageal cancer	2.87e-05	0.000309	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GNG7—esophageal cancer	2.81e-05	0.000303	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYP26A1—esophageal cancer	2.81e-05	0.000302	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CA2—esophageal cancer	2.8e-05	0.000301	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.74e-05	0.000294	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ALOX15—esophageal cancer	2.74e-05	0.000294	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GSTT1—esophageal cancer	2.73e-05	0.000294	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CYP2A6—esophageal cancer	2.7e-05	0.00029	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ELMO1—esophageal cancer	2.66e-05	0.000286	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—TP53—esophageal cancer	2.66e-05	0.000286	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ALDH2—esophageal cancer	2.64e-05	0.000283	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—TPI1—esophageal cancer	2.61e-05	0.000281	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GSTO1—esophageal cancer	2.61e-05	0.000281	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PLCE1—esophageal cancer	2.6e-05	0.00028	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ADH7—esophageal cancer	2.6e-05	0.00028	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AKAP13—esophageal cancer	2.6e-05	0.00028	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.57e-05	0.000277	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ENO1—esophageal cancer	2.56e-05	0.000275	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PTGS1—esophageal cancer	2.56e-05	0.000275	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.56e-05	0.000275	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PSME2—esophageal cancer	2.52e-05	0.000271	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PSME1—esophageal cancer	2.52e-05	0.000271	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GSTT1—esophageal cancer	2.51e-05	0.00027	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ALDOB—esophageal cancer	2.5e-05	0.000269	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GAPDH—esophageal cancer	2.41e-05	0.000259	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HIST1H2BM—esophageal cancer	2.4e-05	0.000258	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CRABP1—esophageal cancer	2.39e-05	0.000257	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PDE4D—esophageal cancer	2.38e-05	0.000256	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PTGS1—esophageal cancer	2.35e-05	0.000253	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ENO1—esophageal cancer	2.35e-05	0.000253	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PSME2—esophageal cancer	2.32e-05	0.000249	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PSME1—esophageal cancer	2.32e-05	0.000249	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ADH1B—esophageal cancer	2.28e-05	0.000245	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GNG7—esophageal cancer	2.27e-05	0.000244	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GNG7—esophageal cancer	2.26e-05	0.000243	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—TYMP—esophageal cancer	2.18e-05	0.000234	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CYP1B1—esophageal cancer	2.18e-05	0.000234	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ALDH2—esophageal cancer	2.13e-05	0.000229	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP26A1—esophageal cancer	2.12e-05	0.000228	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—XIAP—esophageal cancer	2.12e-05	0.000228	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ALOX15—esophageal cancer	2.07e-05	0.000222	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CYP19A1—esophageal cancer	2.05e-05	0.00022	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GSTT1—esophageal cancer	2.02e-05	0.000218	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CTNNA1—esophageal cancer	2.01e-05	0.000215	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYP2A6—esophageal cancer	2e-05	0.000215	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CYP1B1—esophageal cancer	2e-05	0.000215	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CXCL2—esophageal cancer	1.99e-05	0.000214	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—TPI1—esophageal cancer	1.97e-05	0.000212	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GSTO1—esophageal cancer	1.97e-05	0.000212	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ENO1—esophageal cancer	1.9e-05	0.000204	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PTGS1—esophageal cancer	1.9e-05	0.000204	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ALDOB—esophageal cancer	1.89e-05	0.000203	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CYP19A1—esophageal cancer	1.88e-05	0.000202	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PSME2—esophageal cancer	1.87e-05	0.000201	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PSME1—esophageal cancer	1.87e-05	0.000201	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—HMOX1—esophageal cancer	1.87e-05	0.000201	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PSME2—esophageal cancer	1.86e-05	0.0002	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PSME1—esophageal cancer	1.86e-05	0.0002	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ANXA1—esophageal cancer	1.85e-05	0.000199	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GAPDH—esophageal cancer	1.82e-05	0.000196	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CRABP1—esophageal cancer	1.8e-05	0.000194	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SST—esophageal cancer	1.8e-05	0.000194	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ABCB1—esophageal cancer	1.79e-05	0.000193	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NOTCH3—esophageal cancer	1.76e-05	0.000189	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GHRL—esophageal cancer	1.76e-05	0.000189	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—FBXW7—esophageal cancer	1.73e-05	0.000186	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GNG7—esophageal cancer	1.72e-05	0.000184	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—HMOX1—esophageal cancer	1.72e-05	0.000184	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ABCB1—esophageal cancer	1.65e-05	0.000177	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYP1B1—esophageal cancer	1.61e-05	0.000173	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ALDH2—esophageal cancer	1.61e-05	0.000173	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NOTCH2—esophageal cancer	1.58e-05	0.000169	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GSTT1—esophageal cancer	1.53e-05	0.000164	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYP19A1—esophageal cancer	1.52e-05	0.000163	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP2A6—esophageal cancer	1.51e-05	0.000163	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.51e-05	0.000162	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PTGS1—esophageal cancer	1.43e-05	0.000154	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ENO1—esophageal cancer	1.43e-05	0.000154	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PSME2—esophageal cancer	1.41e-05	0.000152	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PSME1—esophageal cancer	1.41e-05	0.000152	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TGFBR2—esophageal cancer	1.4e-05	0.00015	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—HMOX1—esophageal cancer	1.38e-05	0.000149	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ABCB1—esophageal cancer	1.33e-05	0.000143	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SMAD4—esophageal cancer	1.32e-05	0.000142	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.23e-05	0.000133	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP1B1—esophageal cancer	1.22e-05	0.000131	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CREBBP—esophageal cancer	1.2e-05	0.000129	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP19A1—esophageal cancer	1.15e-05	0.000123	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CREBBP—esophageal cancer	1.1e-05	0.000118	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HIF1A—esophageal cancer	1.08e-05	0.000116	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—NOS3—esophageal cancer	1.07e-05	0.000115	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—HMOX1—esophageal cancer	1.05e-05	0.000112	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—KDR—esophageal cancer	1.04e-05	0.000111	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.03e-05	0.00011	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ABCB1—esophageal cancer	1e-05	0.000108	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—NOS3—esophageal cancer	9.85e-06	0.000106	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PTGS2—esophageal cancer	9.81e-06	0.000105	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NOTCH1—esophageal cancer	9.75e-06	0.000105	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PTGS2—esophageal cancer	9.01e-06	9.68e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CREBBP—esophageal cancer	8.88e-06	9.54e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CREBBP—esophageal cancer	8.84e-06	9.5e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—EGFR—esophageal cancer	8.69e-06	9.34e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PIK3CA—esophageal cancer	8.31e-06	8.93e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—EP300—esophageal cancer	8.16e-06	8.77e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—NOS3—esophageal cancer	7.95e-06	8.54e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NOS3—esophageal cancer	7.92e-06	8.51e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.59e-06	8.16e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PIK3CA—esophageal cancer	7.54e-06	8.11e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—EP300—esophageal cancer	7.49e-06	8.05e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ERBB2—esophageal cancer	7.41e-06	7.96e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PTGS2—esophageal cancer	7.27e-06	7.81e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CREBBP—esophageal cancer	6.71e-06	7.21e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCND1—esophageal cancer	6.54e-06	7.03e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CDKN1A—esophageal cancer	6.33e-06	6.8e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—EP300—esophageal cancer	6.05e-06	6.5e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PIK3CA—esophageal cancer	6.04e-06	6.49e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—EP300—esophageal cancer	6.02e-06	6.47e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—NOS3—esophageal cancer	6.01e-06	6.45e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PIK3CA—esophageal cancer	5.54e-06	5.96e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PTGS2—esophageal cancer	5.49e-06	5.9e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MYC—esophageal cancer	5.25e-06	5.64e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—EGFR—esophageal cancer	5.13e-06	5.52e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—EP300—esophageal cancer	4.57e-06	4.91e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PIK3CA—esophageal cancer	4.47e-06	4.81e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PIK3CA—esophageal cancer	4.46e-06	4.79e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TP53—esophageal cancer	4.31e-06	4.63e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PIK3CA—esophageal cancer	3.38e-06	3.63e-05	CbGpPWpGaD
